Development of pyridine-containing macrocyclic copper(II) complexes: Potential role in the redox modulation of oxaliplatin toxicity in human breast cells

Free Radical Research

Volumn 46, Issue 9, 2012, Pages 1157-1166

  Fernandes, Ana S ^a,b   Costa, Judite ^a   Gaspar, Jorge ^c   Rueff, José ^c   Cabral, M Fátima ^a   Cipriano, Madalena ^a   Castro, Matilde ^a   Oliveira, Nuno G ^a  

^a RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^b UNIVERSIDADE LUSÓFONA DE HUMANIDADES E TECNOLOGIAS   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

Breast cancer; Macrocyclic copper(II) complexes; Oxaliplatin; Superoxide dismutase mimetics

Indexed keywords

COPPER; MACROCYCLIC COMPOUND; OXALIPLATIN; PYRIDINE; SCAVENGER; SUPEROXIDE;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CYTOTOXICITY; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CELL SURVIVAL; COPPER; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FREE RADICAL SCAVENGERS; HUMANS; HYDROGEN-ION CONCENTRATION; HYDROXYL RADICAL; MACROCYCLIC COMPOUNDS; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; ORGANOPLATINUM COMPOUNDS; OXIDATION-REDUCTION; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDES; THERMODYNAMICS; TUMOR CELLS, CULTURED;

EID: 84864662657     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2012.695869     Document Type: Article

References (53)

1. Duncan C, White AR. Copper complexes as therapeutic agents. Metallomics 2012;4:127-138.
2. Oberley LW. Mechanism of the tumor suppressive eff ect of MnSOD overexpression. Biomed Pharmacother 2005;59: 143-148. (Pubitemid 40603325)
3. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. New York: Oxford University Press; 2007.
4. Batinic-Haberle I, Rebou ç as JS, Spasojevi ? I. Superoxide dis- mutase mimics: chemistry, pharmacology and therapeutic potential. Antiox Redox Signal 2010;13:877-918.
5. Salvemini D, Riley DP, Cuzzocrea S. SOD mimetics are com- ing of age. Nat Rev Drug Discov 2002;1:367-374. (Pubitemid 37361466)
6. Matés JM. Eff ects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000;153:83-104.
7. Riley DP. Functional mimics of superoxide dismutase enzymes as therapeutic agents. Chem Rev 1999;99:2573-2588.
8. Fernandes AS, Gaspar J, Cabral MF, Caneiras C, Guedes R, Rueff J, et al. Macrocyclic copper(II) complexes: superoxide scavenging activity, structural studies and cytotoxicity evalua- tion. J Inorg Biochem 2007;101:849-858. (Pubitemid 46529006)
9. Bienvenue E, Choua S, Lobo-Recio M-A, Marzin C, Pacheco P, Seta P, et al. Structure and superoxide dismutase activity of Ru(II), Cu(II), and Mn(II) macrocyclic complexes. J Inorg Bio- chem 1995;57:157-168.
10. Kimura E, Sakonaka A, Nakamoto M. Superoxide dismutase activity of macrocyclic polyamine complexes. Biochim Bio- phys Acta 1981;678:172-179.
11. Kimura E, Yatsunami A, Watanabe A, Machida R, Koike T, Fujioka H, et al. Further studies on superoxide dismutase activities of macrocyclic polyamine complexes of copper(II). Biochim Biophys Acta 1983;745:37-43.
12. Langan AR, Khan MA, Yeung IW, Van Dyk J, Hill RP. Partial volume rat lung irradiation: the protective/mitigating eff ects of Eukarion-189, a superoxide dismutase-catalase mimetic. Radi- other Oncol 2006;79:231-238. (Pubitemid 43884942)
13. Oury TD, Thakker K, Menache M, Chang LY, Crapo JD, Day BJ. Attenuation of bleomycin-induced pulmonary fi brosis by a catalytic antioxidant metalloporphyrin. Am J Respir Cell Mol Biol 2001;25:164-169. (Pubitemid 32752441)
14. Kaiserova H, den Hartog GJ, Simunek T, Schroterova L, Kvasnickova E, Bast A. Iron is not involved in oxidative stress- mediated cytotoxicity of doxorubicin and bleomycin. Br J Pharmacol 2006;149:920-930. (Pubitemid 44851716)
15. Konorev EA, Kennedy MC, Kalyanaraman B. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics aff ord superior protection against doxorubicin-induced cardio- toxicity: the role of reactive oxygen and nitrogen intermediates. Arch Biochem Biophys 1999;368:421-428. (Pubitemid 29406570)
16. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A, et al. Controlling tumor growth by modulating endog- enous production of reactive oxygen species. Cancer Res 2005;65:948-956. (Pubitemid 40216456)
17. Francisco DC, Peddi P, Hair JM, Flood BA, Cecil AM, Kalogerinis PT, et al. Induction and processing of complex DNA damage in human breast cancer cells MCF-7 and nonmalignant MCF-10A cells. Free Radic Biol Med 2008;44:558-569. (Pubitemid 351192932)
18. Li JJ, Oberley LW, St Clair DK, Ridnour LA, Oberley TD. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dis- mutase. Oncogene 1995;10:1989-2000.
19. Weydert CJ, Waugh TA, Ritchie JM, Iyer KS, Smith JL, Li L, et al. Overexpression of manganese or copper-zinc superoxide dismutase inhibits breast cancer growth. Free Radic Biol Med 2006;41:226-237. (Pubitemid 43928496)
20. Nicco C, Laurent A, Chereau C, Weill B, Batteux F. Diff eren- tial modulation of normal and tumor cell proliferation by reac- tive oxygen species. Biomed Pharmacother 2005;59:169-174. (Pubitemid 40603329)
21. Alexandre J, Nicco C, Chereau C, Laurent A, Weill B, Gold-wasser F, et al. Improvement of the therapeutic index of anti-cancer drugs by the superoxide dismutase mimic mangafodipir. J Natl Cancer Inst 2006;98:236-244. (Pubitemid 43264707)
22. Keele BB Jr, McCord JM, Fridovich I. Further characterization of bovine superoxide dismutase and its isolation from bovine heart. J Biol Chem 1971;246:2875-2880.
23. Costa J, Delgado R. Metal complexes of macrocyclic ligands containing pyridine. Inorg Chem 1993;32:5257-5265.
24. Costa J, Delgado R, Drew MGB, F é lix V. Design of selective macrocyclic ligands for the divalent fi rst-row transition-metal ions. J Chem Soc Dalton Trans 1998:1063-1071. (Pubitemid 128757213)
25. Fernandes AS, Cabral MF, Costa J, Castro M, Delgado R, Drew MGB, et al. Two macrocyclic pentaaza compounds containing pyridine evaluated as novel chelating agents in copper(II) and nickel(II) overload. J Inorg Biochem 2011;105:410-419.
26. Schwarzenbach G, Flaschka HA. Complexometric titrations. London: Methuen and Co; 1969.
27. Delagrange S, Delgado R, Nepveu F. Mn2 +, Co2 +, Cu2+ and Zn2+complexes with two macrocyclic ligands bearing L-lactate-like functions: potentiometric studies and evaluation of superoxide-scavenging properties of the Mn2+ complex. J Inorg Biochem 2000;81:65-71.
28. Alderighi L, Gans P, Ienco A, Peters D, Sabatini A, Vacca A. Hyperquad simulation and speciation (HySS): a utility pro-gram for the investigation of equilibria involving soluble and partially soluble species. Coord Chem Rev 1999;184: 311-318.
29. Pettit LD, Powell KJ. IUPAC Stability constants database. UK: Academic Software, Sourby Old Farm, Timble, Ottley, Yorks.; 2004.
30. Smith RM, Martell AE, Motekaitis RJ. Nist Critical stability constants of metal complexes database. Gaithersburg: U.S. Department of Commerce; 1998.
31. X avier S, Yamada K, Samuni AM, Samuni A, DeGraff W, Krishna MC, et al. Diff erential protection by nitroxides and hydroxylamines to radiation-induced and metal ion-catalyzed oxidative damage. Biochim Biophys Acta 2002;1573: 109-120. (Pubitemid 35217932)
32. Mitchell JB. Potential applicability of nonclonogenic measure-ments to clinical oncology. Radiat Res 1988;114:401-414.
33. Fernandes AS, Gaspar J, Cabral MF, Rueff J, Castro M, Batinic-Haberle I, et al. Protective role of ortho-substituted Mn(III) N-alkylpyridylporphyrins against the oxidative injury induced by tert-butylhydroperoxide. Free Radic Res 2010;44: 430-440.
34. Fernandes AS, Serejo J, Gaspar J, Cabral F, Bettencourt AF, Rueff J, et al. Oxidative injury in V79 Chinese hamster cells: protective role of the superoxide dismutase mimetic MnTM-4-PyP. Cell Biol Toxicol 2010;26:91-101.
35. .- scaven-ger activity: Cu(II)-peptide complexes as superoxide dismutase models. J Inorg Biochem 1999;73:157-165. (Pubitemid 29226609)
36. 2-scavenger activity. J Inorg Biochem 1993;50:273-281.
37. Costamagna J, Ferraudi G, Matsuhiro B, Campos-Vallette M, Canales J, Villagr á n M, et al. Complexes of macrocycles with pendant arms as models for biological molecules. Coord Chem Rev 2000;196:125-164.
38. Gonzalez-Alvarez M, Alzuet G, Borras J, Castillo Agudo L, Montejo-Bernardo JM, Garcia-Granda S. Development of novel copper(II) complexes of benzothiazole-N-sulfonamides as pro-tective agents against superoxide anion. Crystal structures of Cu(N-2-(4-methylbenzothiazole)benzenesulfonamidate)(2) (py)(2) and Cu(N-2-(6-nitrobenzothiazole)naphthalenesulfon-amidate)(2)(py)(2). J Biol Inorg Chem 2003;8:112-120. (Pubitemid 36168899)
39. Lindoy LF. Tailoring macrocycles for metal ion binding. Pure Appl Chem 1997;69:2179-2186. (Pubitemid 127482837)
40. Autzen S, Korth H-G, Boese R, de Groot H, Sustmann R. Studies of pyridinyl-containing 14-membered macrocyclic copper(II) complexes. Eur J Inorg Chem 2003:1401-1410.
41. Kang S-G, Kim M-S, Choi J-S, Cho MH. Synthesis, characterization and properties of new fully Λ-alkylated 14-membered tetraaza macrocycles and their copper(II) complexes. Polyhedron 1995;14:781-786.
42. Costa J, Delgado R, Drew MGB, F é lix V, Saint-Maurice A. A new redox-responsive 14-membered tetraazamacrocycle with ferrocenylmethyl arms as receptor for sensing transition-metal ions. J Chem Soc Dalton Trans 2000:1907-1916.
43. Müller J, Schübl D, Maichle-Mössmer C, Strähle J, Weser U. Structure-function correlation of Cu(II)-and Cu(I)-di-Schiff-base complexes during the catalysis of superoxide dismutation J Inorg Biochem 1999;75:63-69. (Pubitemid 29300077)
44. Costa J, Delgado R, Drew MGB, F é lix V, Henriques RT, Waer-enborgh JC. Structural characterization of cobalt(III), nickel(II), copper(II) and iron(III) complexes of tetraazamacrocycles with N-carboxymethyl arms. J Chem Soc Dalton Trans 1999: 3253-3265.
45. Riley DP, Henke SL, Lennon PJ, Weiss RH, Neumann WL, Rivers WJ, et al. Synthesis, characterization, and stability of manganese(II) C-substituted 1,4,7,10,13-pentaazacyclopenta-decane complexes exhibiting superoxide dismutase activity Inorg Chem 1996;35:5213-5231. (Pubitemid 126452948)
46. +) complexes with pyridine-containing 15-membered macrocycles: thermodynamic, kinetic, crystallographic, and (1)H/(17)O relaxation studies. Inorg Chem 2010;49:3224-3238.
47. Durackova Z, Mendiola MA, Sevilla MT, Valent A. Thiohy-drazone copper(II) complexes. The relationship between redox properties and superoxide dismutase mimetic activity. Bioelec-trochemBioenerg 1999;48:109-116. (Pubitemid 29150369)
48. Szilagyi I, Labadi I, Hernadi K, Palinko I, Nagy NV, Korecz L, et al. Speciation study of an imidazolate-bridged copper(II)-zinc(II) complex in aqueous solution. J Inorg Biochem 2005;99:1619-1629. (Pubitemid 41039921)
49. Patel RN, Gundla VLN, Patel DK. Synthesis, structure and properties of some copper(II) complexes containing an ONO donor Schiff base and substituted imidazole ligands. Polyhe-dron2008;27:1054-1060.
50. Raman N, Sakthivel A, Jeyamurugan R. Binuclear copper and zinc complexes possessing bio-potential ligands: synthesis, characterization, antimicrobial, SOD mimetic, DNA binding, and cleavage studies. J Coord Chem 2010;63:1080-1096.
51. Decatris MP, Sundar S, O'Byrne KJ. Platinum-based chemo-therapy in metastatic breast cancer: current status. Cancer Treat Rev 2004;4:53-81. (Pubitemid 38240088)
52. Kim S, Lee TJ, Park JW, Kwon TK. Overexpression of cFLIPs inhibits oxaliplatin-mediated apoptosis through enhanced XIAP stability and Akt activation in human renal cancer cells. J Cell Biochem 2008;105:971-979.
53. Ohse T, Nagaoka S, Arakawa Y, Kawakami H, Nakamura K. Cell death by reactive oxygen species generated from water-soluble cationic metalloporphyrins as superoxide dismutase mimics. J Inorg Biochem 2001;85:201-208. (Pubitemid 32618650)